Nonetheless, the present study has shown that existence of DIC is common in deaths with NCP; abnormal coagulation results, especially markedly elevated D‐dimer and FDP, may have the potential to guide therapy and evaluate prognosis.N. Warfarin embryopathy is characterized by Warfarin was not present in human milk from mothers treated with warfarin from a limited published
A novel coronavirus from patients with pneumonia in China, 2019Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyClinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaClinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, ChinaClinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidanceTowards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulationUse of soluble fibrin antigen instead of D‐dimer as fibrin‐related marker may enhance the prognostic power of the ISTH overt DIC scoreThrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC)Mechanisms of severe acute respiratory syndrome coronavirus‐induced acute lung injuryPlasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysisComplement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases, SARS-CoV-2 and viral sepsis: observations and hypotheses, Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response, Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, COVID-19 cytokine storm: the interplay between inflammation and coagulation, Journal of Cardiothoracic and Vascular Anesthesia, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, Acute limb ischemia in patients with COVID-19 pneumonia, Acute thrombosis of an aortic prosthetic graft in a patient with severe COVID-19 related pneumonia, Arterial and venous thromboembolic disease in a patient with COVID-19: A case report, Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms, Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action, Chirped polarization volume grating for wide FOV and high‐efficiency waveguide‐based AR displays, The Manipulation of Molecular Aggregation Behavior: Underwater Superoleophobic/Underoil Superhydrophobic Gels from the Same Matrix for Oil/Water Separation, Potential of heparin and nafamostat combination therapy for COVID‐19, Exploring possible mechanisms for COVID‐19 induced thrombocytopenia: Unanswered questions, The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome, Response to ‘Inaccurate conclusions by Tang and colleagues’, Identification and validation of potential flood hazard area using GIS‐based multi‐criteria analysis and satellite data‐derived water index, Investigating the Role of Cloud‐Radiation Interactions in Subseasonal Tropical Disturbances, Do the Affluent Override Average Americans?
All antibodies were obtained from BD Biosciences (San Diego, Calif). bleeding, and clinical circumstances.